Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review
暂无分享,去创建一个
K. Tao | Guoxin Li | Peng Zhang | Chang-ming Huang | C. Du | Yong Li | Xing-Yu Feng | Zifeng Yang | H. Qiu | Yongjian Zhou | Xiufeng Liu | G. Zheng | X. Yin | Zhiwei Zhou | Fang Pan | Tao Chen
[1] F. van Coevorden,et al. Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients. , 2017, European journal of cancer.
[2] K. Tao,et al. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China , 2017, Cancer medicine.
[3] A. Muratore,et al. Pulmonary Complications after Surgery for Rectal Cancer in Elderly Patients: Evaluation of Laparoscopic versus Open Approach from a Multicenter Study on 477 Consecutive Cases , 2017, Gastroenterology research and practice.
[4] T. Yamano,et al. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study. , 2017, European journal of cancer.
[5] P. Zhang,et al. Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study , 2017, Journal of Gastrointestinal Surgery.
[6] K. Matsuda,et al. Systematic review of laparoscopic vs open surgery for colorectal cancer in elderly patients. , 2016, World journal of gastrointestinal oncology.
[7] H. Gan,et al. Inclusion of elderly patients in oncology clinical trials. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] M. McCarter,et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] K. Søreide,et al. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. , 2016, Cancer epidemiology.
[10] L. Harlan,et al. Gastrointestinal stromal tumors: Treatment patterns of a population‐based sample , 2015, Journal of surgical oncology.
[11] U. Knippschild,et al. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST) , 2015, BMC Cancer.
[12] G. Antoniou,et al. Laparoscopic colorectal surgery confers lower mortality in the elderly: a systematic review and meta-analysis of 66,483 patients , 2015, Surgical Endoscopy.
[13] J. Sicklick,et al. Epidemiology of Gastrointestinal Stromal Tumors in the Era of Histology Codes: Results of a Population-Based Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[14] E. Wu,et al. Treatment Patterns, Prescribing Decision Drivers, and Predictors of Complete Response Following Disease Recurrence in Gastrointestinal Stromal Tumor Patients—a Chart Extract-Based Approach , 2014, Journal of Gastrointestinal Cancer.
[15] R. Kapoor,et al. Five‐year follow up of patients with gastrointestinal stromal tumor: Recurrence‐free survival by risk group , 2013, Asia-Pacific journal of clinical oncology.
[16] Aki Vehtari,et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. , 2012, JAMA.
[17] P. Went,et al. Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study. , 2011, Human pathology.
[18] Masayuki Yoshida,et al. Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation , 2010, British Journal of Cancer.
[19] D. Park,et al. Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004 , 2010, Journal of Korean medical science.
[20] C. Antonescu,et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[21] M. Federico,et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study , 2007, BMC Cancer.
[22] J. Cheville,et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness , 2005, Cancer.
[23] L. Rikkers,et al. The society for surgery of the alimentary tract postgraduate course , 1991 .
[24] M. McCarter,et al. Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[25] A. Lacy,et al. Giant Gastric Gastrointestinal Stromal Tumor (GIST) , 2016, Journal of Gastrointestinal Surgery.